Clinical Trial Update: Evaluate the Efficacy and Safety of Multiple Roxadustat Dosing Regimens for the Treatment of Anemia in Dialysis Participants With Chronic Kidney Disease [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating multiple dosing regimens of roxadustat for anemia in dialysis-dependent chronic kidney disease; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia in Dialysis Participants
• Chronic Kidney Disease

Drugs mentioned

• Roxadustat (roxadustat)

Snippet

Sponsor: Kyntra Bio | Conditions: CKD Anemia in Dialysis Participants | Phase 4 | Status: COMPLETED